Jin-hong H. Shin

Yangsan, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 91 publications

Prevalence and Relative Proportions of MS, NMOSD, and MOGAD in the Republic of Korea.

Prevalence and Relative Proportions of MS, NMOSD, and MOGAD in the Republic of Korea.

Journal: Neurology

Published: May 15, 2026

Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the Republic of Korea.

Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the Republic of Korea.

Journal: Neurology

Published: March 12, 2026

27-Hydroxycholesterol inhibits muscle cell viability via mitochondrial dysfunction: Protective role of ROS-induced HIF-1α.

27-Hydroxycholesterol inhibits muscle cell viability via mitochondrial dysfunction: Protective role of ROS-induced HIF-1α.

Journal: Free radical biology & medicine

Published: November 25, 2025

Confirmatory long-term efficacy and safety results of ataluren in patients with nmDMD from Study 041, an international, randomized, double-blind, placebo-controlled, Phase III trial.

Confirmatory long-term efficacy and safety results of ataluren in patients with nmDMD from Study 041, an international, randomized, double-blind, placebo-controlled, Phase III trial.

Journal: Journal of comparative effectiveness research

Published: August 22, 2025

Pharmacokinetics and clinical efficacy of 6'-sialyllactose in patients with GNE myopathy: Randomized pilot trial.

Pharmacokinetics and clinical efficacy of 6'-sialyllactose in patients with GNE myopathy: Randomized pilot trial.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 06, 2023

Life-Saving Treatments for Spinal Muscular Atrophy: Global Access and Availability.

Life-Saving Treatments for Spinal Muscular Atrophy: Global Access and Availability.

Journal: Neurology. Clinical practice

Published: June 01, 2023

Clinical, electrophysiological, and genetic characteristics of cerebrotendinous xanthomatosis in South Korea.

Clinical, electrophysiological, and genetic characteristics of cerebrotendinous xanthomatosis in South Korea.

Journal: Neurocase

Published: February 21, 2023

Neuropsychological, neuroimaging and autopsy findings of butane encephalopathy.

Neuropsychological, neuroimaging and autopsy findings of butane encephalopathy.

Journal: BMC neurology

Published: February 08, 2023

Lifelong Outcomes of Systemic Adeno-Associated Virus Micro-Dystrophin Gene Therapy in a Murine Duchenne Muscular Dystrophy Model.

Lifelong Outcomes of Systemic Adeno-Associated Virus Micro-Dystrophin Gene Therapy in a Murine Duchenne Muscular Dystrophy Model.

Journal: Human gene therapy

Published: December 14, 2022

Clinicopathological Reclassification of Idiopathic Inflammatory Myopathy to Match the Serological Results of Myositis-Specific Antibodies.

Clinicopathological Reclassification of Idiopathic Inflammatory Myopathy to Match the Serological Results of Myositis-Specific Antibodies.

Journal: Journal of clinical neurology (Seoul, Korea)

Published: November 10, 2022

Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum.

Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: November 08, 2022

A novel nonsense mutation in the dimerization domain of FLNC causing mild myofibrillar myopathy.

A novel nonsense mutation in the dimerization domain of FLNC causing mild myofibrillar myopathy.

Journal: Clinical neurology and neurosurgery

Published: March 04, 2022

Showing 1-12 of 91

Last Updated: 09/26/2026